E-LIB Suche - Ergebnisse für: Germinaro, M

1

OP23 Guselkumab induction restores intestinal immune homeos..:

Sridhar, S ; Hart, A ; Venkat, S...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i41-i41 , 2024

Link: https://doi.org/10.1093/..

2

P954 Cumulative response to guselkumab through week 24 of i..:

Rubin, D ; Sands, B ; Lichtenstein, G...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1732-i1733 , 2024

Link: https://doi.org/10.1093/..

3

DOP52 Guselkumab improves symptoms of fatigue in patients w..:

Dignass, A ; Panés, J ; Rubin, D T...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i166-i167 , 2024

Link: https://doi.org/10.1093/..

4

DOP54 Guselkumab and golimumab combination induction therap..:

Richards, D ; Vetter, M ; Germinaro, M...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i171-i172 , 2024

Link: https://doi.org/10.1093/..

5

P213 ArgesMES: A high-performance, generalizable AI model f..:

Chaitanya, K ; Zemlianskaia, N ; Damasceno, P...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i536-i536 , 2024

Link: https://doi.org/10.1093/..

6

P1010 Guselkumab improves abdominal pain and bowel urgency ..:

Rubin, D ; Panés, J ; Feagan, B...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1825-i1826 , 2024

Link: https://doi.org/10.1093/..

7

P294 ArgesUCEIS: A high-performance, generalizable AI model..:

Chaitanya, K ; Zemlianskaia, N ; Damasceno, P...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i665-i666 , 2024

Link: https://doi.org/10.1093/..

8

DOP49 Guselkumab improves health-related quality of life as..:

Panés, J ; Dignass, A ; Lichtenstein, G...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i161-i162 , 2024

Link: https://doi.org/10.1093/..

9

P493 QUASAR Induction Study 1 Cumulative Response to Guselk..:

Peyrin-Biroulet, L ; Rubin, D ; Lichtenstein, G...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i624-i625 , 2023

Link: https://doi.org/10.1093/..

10

OP23 The efficacy and safety of guselkumab induction therap..:

Dignass, A ; Rubin, D ; Bressler, B...
Journal of Crohn's and Colitis. 16 (2022) Supplement_1 - p. i025-i026 , 2022

Link: https://doi.org/10.1093/..

11

P328 In silico evaluation and pre-clinical efficacy of anti..:

Perrigoue, J ; Muniz-Bongers, L ; Ong, L...
Journal of Crohn's and Colitis. 16 (2022) Supplement_1 - p. i348-i348 , 2022

Link: https://doi.org/10.1093/..

12

OP36 Efficacy and safety of combination induction therapy w..:

Sands, B E ; Feagan, B G ; Sandborn, W J...
Journal of Crohn's and Colitis. 16 (2022) Supplement_1 - p. i042-i043 , 2022

Link: https://doi.org/10.1093/..

13

OP28 The effect of guselkumab induction therapy on early cl..:

Danese, S ; Sandborn, W J ; Feagan, B G...
Journal of Crohn's and Colitis. 15 (2021) Supplement_1 - p. S027-S028 , 2021

Link: https://doi.org/10.1093/..

14

Differential Expression of MAPK Activators and Phosphatases..:

Alam, R. ; Goplen, N. ; Liang, Q...
Journal of Allergy and Clinical Immunology. 127 (2011) 2 - p. AB57-AB57 , 2011

Link: https://doi.org/10.1016/..

15

Su1732 GUSELKUMAB INDUCTION RESTORES INTESTINAL IMMUNE HOME..:

Sridhar, Sunan ; Hart, Amy ; Venkat, Swati...
Gastroenterology. 166 (2024) 5 - p. S-790 , 2024

Link: https://doi.org/10.1016/..